Akilis Theoharidis
Foot Surgery · Gladstone, MONPI 1912933474
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $71,768 of the $99,643 with a category attached, or 72.0%. GRT US Holding, Inc. accounts for 62.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $56,388 and has fallen 90.5% since, to $5,385 in 2025. Among foot surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $696.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GRT US Holding, Inc.$62K
- Averitas Pharma Inc.$37K
- Mimedx Group, Inc.$167
- Advanced Oxygen Therapy Inc.$83
- Johnson & Johnson$59
- Bone Support Inc.$57
- plus $266 from 8 others
What the payments were for
- Consulting fees$6,6257%
- Speaking & faculty fees$71,76872%
- Travel & lodging$18,54619%
- Food & beverage$2,6893%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GRT US Holding, Inc. | 86 | $61,766 |
| Averitas Pharma Inc. | 35 | $37,246 |
| Mimedx Group, Inc. | 4 | $167 |
| Advanced Oxygen Therapy Inc. | 1 | $83 |
| Johnson & Johnson(2 entities) | 3 | $59 |
| Bone Support Inc. | 1 | $57 |
| Polynovo North America LLC | 2 | $56 |
| ANI Pharmaceuticals, Inc. | 3 | $49 |
| Smith+Nephew | 2 | $48 |
| Stryker | 2 | $44 |
| Vertex | 1 | $26 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Celularity Inc. | 1 | $17 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$97,666
How this compares
$99,643 in reported general payments places this provider in the 95th percentile of 21 foot surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 30 | $4,499 |
| Ciclopirox | 103 | $3,784 |
| Ammonium Lactate | 76 | $1,917 |
| Gabapentin | 21 | $165 |
| Methylprednisolone | 24 | $147 |
| Cephalexin | 29 | $138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $110 |
| Azithromycin | 32 | $96 |
| Meloxicam | 21 | $24 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Gladstone
- Thomas HewittGladstone$2K
- Jody McAleerJefferson City$3.6M
- Mark SeidenSpringfield$20K
- Stephen PalmerKansas City$10K
- Robert BondiLees Summit$10K
- Laurel BondiLees Summit$5K
- Ronald LoucksFestus$4K
- Joel FosterLee's Summit$2K
- Anthony SikoutrisSedalia$1K
- John RileyKansas City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.